期刊文献+

慢性病毒性乙型肝炎患者血清肝纤维化指标检测的临床意义 被引量:7

Clinical significance of the serum fibrosis parameters in Chronic hepatitis B patients
原文传递
导出
摘要 目的 探讨慢性病毒性乙型肝炎(乙肝)患者血清肝纤维化指标水平与临床的关系。方法 应用放射免疫法及化学发光法检测146例慢性病毒性乙型肝炎患者及40例健康人(对照组)血清肝纤维化指标血清透明质酸(HA)、Ⅳ型胶原(IV-C)、层粘连蛋白(LN)及Ⅲ型前胶原(PCⅢ)水平,并就上述指标与临床肝功能指标关系进行分析。结果 慢性乙肝患者血清HA、IV-C、LN、PCⅢ水平均不同程度高于对照组(P〈0.05或P〈0.01),在不同病程之间差异有统计学意义(P〈0.05或P〈0.01);慢性乙肝患者血清IV-C、PCⅢ水平与血浆PT呈正相关,HA、IV-C、LN水平与Alb呈负相关,HA水平与TBil呈正相关,PCⅢ水平与ALT呈正相关,LN水平与CHE呈负相关。结论 检测慢性病毒性乙型肝炎患者血清HA、IV-C、LN、PCⅢ水平,可反映肝纤维化进展情况和肝功能损害程度。 Objective To study the relationship between serum fibrosis parameters levels and chronic viral hepatitis B patients.Methods Radioimmunoassay and chemiluminescence were used to test the levels of hyaluronic acid(HA),collagen type IV(IV-C),laminin(LN) and procollagen type III(PC III) in 146 cases of chronic hepatitis B and 40 of normal controls,and the relationship with clinical parameters of liver function were analyzed.Results The levels of HA,IV-C,LN,PC Ⅲ in chronic hepatitis B patients were higher than those of normal control group(P〈0.05 or P〈0.01),there were statistical differen in different course of disease(P〈0.05 or P〈0.01);The levels of serum IV-C and PCⅢ had positive correlation with plasma PT,the same to HA with TBil and PCⅢ with ALT;The levels of HA,IV-C and LN had negative correlation with Alb,the same to LN with CHE.Conclusion The levels of HA,IV-C,LN and PCⅢ in chronic hepatitis B patients may reflect the situations of hepatic fibrosis and the degrees of liver function damage.
出处 《中国基层医药》 CAS 2012年第21期3222-3223,共2页 Chinese Journal of Primary Medicine and Pharmacy
关键词 肝炎 乙型 慢性 肝硬化 胶原Ⅳ型 透明质酸 层粘连蛋白 胶原Ⅲ型 Hepatitis B,Chronic Liver cirrhosis Collagen type IV Hyaluronic acid Laminin Collagen type III
  • 相关文献

参考文献6

二级参考文献21

共引文献165

同被引文献65

  • 1林少锐,陈瑞烈,郑晓丹,康惠忠.慢性肝病血清肝纤维化指标检测的临床意义[J].世界感染杂志,2006,6(3):225-226. 被引量:12
  • 2邵彬,聂青和,张亚飞,苟艳子.肝病患者血清中TIMP-1与HA、PCⅢ、CⅣ、LN水平的相关性[J].胃肠病学和肝病学杂志,2006,15(3):254-257. 被引量:8
  • 3黄宁,曾令兰,李淑莉,苏凤菊.TGF-β_1、BMP-7 mRNA在实验性肝纤维化中的表达及意义[J].微循环学杂志,2007,17(3):19-21. 被引量:4
  • 4中华医学会肝病学分会 中华医学会感染病学分会.慢性乙型肝炎防治指南.中华肝脏病杂志,2010,19(1):3760-3769.
  • 5Zeng MD, Lu LG, Mao YM, et al. Prediction of significant fibrosis in HBeAg-positive patients with chronic hepatitis B by a noninva- sire model. Hepatoiogy,2005,42 (6) : 1437-1445.
  • 6郑筱萸.中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,2011:371-372.
  • 7Biqer K,Ari A,GengVE,et al.Efficacy of entecavir treatment among chronic hepatitis B nucleos(t)ide-naive and- experienced patients [J/ .Turk J Med Sci,2015,45(1):99-104.
  • 8Bialek SR,Helgenberger L,Fischer GE.Impact of routine hepatitis B immunization on the prevalence of chronic hepatitis B virus infection in the marshall islands and the federated States ofmicronesia [J] .PediatrlnfectDisJ,2010,29(1):18-22.
  • 9Wong GL,Chan HL,Chan HY, et al.Serum interferon-inducible protein 10 levels predict hepatitis B s antigen seroclearance in patients with chronic hepatitis B[ J] .Aliment Pharmacol Ther,2016,43(1): 145-153.
  • 10Ruan P,Zhou B,Dai X,et al.Predictive value of intrahepatic hepatitis B virus covalently closed circular DNA and total DNA in patients with acute hepatitis B and patients with chronic hepatitis B receiving anti-viral treatment [J] . Mol Med Rep,2014,9(4): 1135-1141.

引证文献7

二级引证文献51

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部